N-Acetyl-D-leucine

Name: N-Acetyl-D-leucine | 19764-30-8
Brand: US-CATO
SKU: S57CPTD788392_100_MG
Price: 19998.0 USD
Availability: OutOfStock

Cat. No S57CPTD788392_100_MG

Vendor: US-CATO

Product Information

Product Name

N-Acetyl-D-leucine

Brand Name

US-CATO

Product Number

CPTD788392

CAS

19764-30-8

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

1241420

IUPAC Name

(2R)-2-acetamido-4-methylpentanoic acid

InChI Key

WXNXCEHXYPACJF-SSDOTTSWSA-N

SMILES

CC(C)CC@H(C(=O)O)NC(=O)C

References Data Source From Pubchem

Non-ribosomal peptide cyclase-directed chemoenzymatic synthesis of lariat lipopeptides

Publication Name: Nature Chemistry

Publication Date: 2025-11-04

DOI: 10.1038/s41557-025-01979-6

The Latest Developments for the Treatment of Ataxia Telangiectasia: A Narrative Review

Publication Name: Cerebellum (London, England)

Publication Date: 2024-09-27

DOI: 10.1007/s12311-024-01746-2

N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study

Publication Name: Trials

Publication Date: 2023-05-29

DOI: 10.1186/s13063-023-07399-6

A master protocol to investigate a novel therapy acetyl-l-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia

Publication Name: Trials

Publication Date: 2021-01-22

DOI: 10.1186/s13063-020-05009-3

Catalytic properties of aminoacylase of strain Rhodococcus armeniensis AM6.1

Publication Name: Applied Biochemistry and Microbiology

Publication Date: 2016-05-19

DOI: 10.1134/s0003683816030029

N-Acetyl-D-leucine

Product Information

General Information

References Data Source From Pubchem

Non-ribosomal peptide cyclase-directed chemoenzymatic synthesis of lariat lipopeptides

The Latest Developments for the Treatment of Ataxia Telangiectasia: A Narrative Review

N-acetyl-L-leucine for Niemann-Pick type C: a multinational double-blind randomized placebo-controlled crossover study

A master protocol to investigate a novel therapy acetyl-l-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia

Catalytic properties of aminoacylase of strain Rhodococcus armeniensis AM6.1